Amanda June Shapiro

Amanda June Shapiro

Auto-generated profile, based on publicly available information

Amanda June Shapiro

Affiliation Sydney School of Veterinary Science, The University of Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2020 in Zoonoses and Public Health
Verified
Journal Article
Closed access
PDF file
ASAmanda Shapiro
Amanda Shapiro
KBKatrina Bosward
Katrina Bosward
KMKaren Mathews
Karen Mathews
GVGemma Vincent
Gemma Vincent
JSJohn Stenos
John Stenos
JNJacqueline M. Norris
Jacqueline M. Norris

15 August 2017 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
ASAmanda J. Shapiro
Amanda J. Shapiro
GBGraeme Brown
Graeme Brown
JNJacqueline M. Norris
Jacqueline M. Norris
KBKatrina Bosward
Katrina Bosward
DMDebbie J. Marriot
Debbie J. Marriot
RMRichard Malik
Richard Malik
Vector-borne diseases of dogs in Australian Aboriginal communities are relatively unexplored. These dogs represent a unique group with variable ecto- and endo-parasitic burdens, nutritional stresses and a general lack of veterinary intervention. We investigated haemoprotozoal and bacterial pathogen prevalences in relation to erythrocyte and platelet numbers in dogs from North-West New South Wales (N-W NSW) and the Northern Territory (NT; Central Australia). Real-time PCR (qPCR) amplification of Anaplasma platys, Babesia vogeli, Mycoplasma haemocanis, Candidatus Mycoplasma haematoparvum and Bartonella spp., serological screening for Coxiella burnetii, and Bartonella spp. and haematological analyses were performed on dogs from the two cohorts (96 dogs in total). Brucella suis serology was determined additionally for the N-W NSW cohort. Anaplasma platys (n = 26 dogs), Babesia vogeli (n = 7), Candidatus Mycoplasma haematoparvum (n = 10 dogs), and Mycoplasma haemocanis (n = 14) were detected in the sample population (n = 96) using qPCR. There were significant associations between (i) A. platys and anaemia (OR 8.7, CI 2.4–31.7; P < 0.001), thrombocytopenia (OR 12.1, CI 3.4–43.2; P < 0.001) and breed (OR 16.1, CI 2.1–121.5; P = 0.007), and (ii) between B. vogeli and anaemia (OR 11.8, CI 2.3–61.6; P = 0.003). Neither protozoal nor bacterial DNA loads, estimated using qPCR, were positively correlated with anaemia or thrombocytopenia. Haemotropic mycoplasmas were not associated with any haematologic abnormality. Four dogs from the NT were seropositive for Coxiella burnetii, while no dogs were seropositive for Brucella suis or to a panel of Bartonella spp. antigens. Despite directed efforts, Bartonella DNA was not detected in blood from any of the cohorts studied. A sample of dogs from the NT recruited specifically for Bartonella α-proteobacteria growth medium enrichment blood culture were also Bartonella PCR negative. Vector-borne pathogens occur in dogs free ranging near Aboriginal communities, with higher detection rates in NT than N-W NSW. The preponderant haematologic abnormalities were anaemia and thrombocytopenia, likely attributable to A. platys and B. vogeli infections, but also probably affected by nutritional, parasitic, lactational and environmental stressors. The absence of Bartonella spp. is of importance to the Australian setting, and work needs to be extended to tropical coastal communities where fleas are present as well as ticks. Dogs living in and around Aboriginal communities may provide valuable sentinel information on disease infection status of human public health significance.

13 September 2016 in Zoonoses and Public Health
Verified
Journal Article
Closed access
PDF file
ASA. J. Shapiro
A. J. Shapiro
JNJacqueline M. Norris
Jacqueline M. Norris
KBK. L. Bosward
K. L. Bosward
JHJ. Heller
J. Heller

30 September 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAmanda June Shapiro
Amanda June Shapiro
BKBenjamin Kimble
Benjamin Kimble
FHFrances Hulst
Frances Hulst
KHKimberly Vinette Herrin
Kimberly Vinette Herrin
CMCaroline Marschner
Caroline Marschner
MGMerran Govendir
Merran Govendir
The pharmacokinetic profile of firocoxib administered orally at 5 mg/kg as a single dose to three mature koalas of each sex is described. After single dose administration, the harmonic means for maximal plasma concentration (Cmax), time to reach Cmax (Tmax) and elimination half-life (t1/2) were 79.2 ng/mL, 3.69 h, and 5.01 h, respectively. Males exhibited a higher Cmax than females (217.4 vs 48.4 ng/mL), suggesting greater oral absorption, while females had a slower elimination (t1/2: 5.87 h vs 4.38 h in males), however these sex differences were not significant. After a wash-out period, the same dose was administered every 12 h, on six occasions to the same koalas. With repeat dosing, females had higher trough concentrations at 24 and 48 h, and 12 h after the last dose, compared to the males. No observable adverse effects were evident in any of the koalas following repeat dosing. The target plasma concentration was approximately 100 ng/mL based on in vitro studies in other species to inhibit 80% of cyclooxygenase-2 activity (inhibitory concentration 80 [IC80]). During single firocoxib administration, this plasma concentration was attained only in the males and not in the females. Two unidentified metabolites were also observed in the chromatograms. Acknowledging the lipophilic nature of firocoxib and that it is therefore likely to persist in animals’ tissues longer than in plasma, firocoxib appears a useful nonsteroidal anti-inflammatory drug for the koala. The oral dose of 5 mg/kg twice a day for a maximum of six doses appears safe for mature male koalas. The data presented here suggests that mature females may require a higher dose (perhaps double the dose i.e., i.e., 10 mg/kg). Until further studies confirm the sex differences in pharmacokinetic profile of firocoxib and safety of higher doses in female koalas, a once daily administration of a higher dose is suggested.